asciminib 20 MG Oral Tablet
- RxCUI
- 2584320
- RxNorm name
- asciminib 20 MG Oral Tablet
- Display name
- asciminib 20 MG Oral Tablet
- Full name
- asciminib 20 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:25
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SCEMBLIX | ASCIMINIB | Novartis Pharmaceuticals Corporation | e33001e7-3650-42b1-ae56-cddb5c43aa2b | 2025-11-25 | Warnings, Adverse reactions | 2584320 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e33001e7-3650-42b1-ae56-cddb5c43aa2b | asciminib 20 MG Oral Tablet | PSN | 12 | These highlights do not include all the information needed to use SCEMBLIX safely and effectively. See full prescribing information for SCEMBLIX . SCEMBLIX ® (asciminib) tablets, for oral use Initial U.S. Approval: 2021 | 20251125 |
| e33001e7-3650-42b1-ae56-cddb5c43aa2b | asciminib 20 MG (equivalent to asciminib HCl 21.62 MG) Oral Tablet | SY | 12 | These highlights do not include all the information needed to use SCEMBLIX safely and effectively. See full prescribing information for SCEMBLIX . SCEMBLIX ® (asciminib) tablets, for oral use Initial U.S. Approval: 2021 | 20251125 |
| e33001e7-3650-42b1-ae56-cddb5c43aa2b | asciminib 20 MG Oral Tablet | SCD | 12 | These highlights do not include all the information needed to use SCEMBLIX safely and effectively. See full prescribing information for SCEMBLIX . SCEMBLIX ® (asciminib) tablets, for oral use Initial U.S. Approval: 2021 | 20251125 |